According to Xeris Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$45.33 M. In 2023 the company made an earning of -A$55.34 M an increase over its 2022 earnings that were of -A$0.13 B.The earnings displayed on this page is the company's Pretax Income.